Abstract This research work explores the development and application of layer-by-layer modified electrochemical apta-sensor for the precise monitoring of HER2, a crucial biomarker associated with breast cancer. The surface of the screen-printed carbon electrode was modified with gold nanoparticle (Au-NP) and TiVC MXene catalyst plus Pb²⁺ loaded aptamer (SPCE/TiVC-MXene/Au NPs/Pb²⁺-aptamer), which showed a high selectivity and affinity toward HER2 and offered a sensitive detection platform. The MXene nano-layer was synthesized and characterized by FT-IR, MAP, EDS, and TEM methods and used as a substrate to improve electrochemical conductivity and loading of biological recognition element. The difference of stripping signals of the Pb²⁺ from the SPCE/TiVC-MXene/Au NPs/Pb²⁺-aptamer before and after incubation in HER2 solution was selected as analytical response to achieve a reliable and quantitative analysis for HER2 concentrations. The results demonstrate a linear dynamic range of 1.0–1200 pg/mL for monitoring of HER2 with limit of detection of 50 fg/mL. Agood affinity of fabricated aptasensor to HER2 in the presence some other biomarkers such as PR, ER, and CEA confirmed the selectivity of the fabricated biosensor towards HER2.
No takes yet. Share an insight, caveat, or question.
Zare et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: